The arrival of a Japanese encephalitis (JE) vaccine in communities across Asia has inspired celebration and transformed lives. At each step in the vaccine’s 11-year journey from the Chinese manufacturer to cities and remote villages, PATH and our partners were there to dismantle the barriers that threatened to keep it from reaching children at risk.
An estimated 14 million children received the vaccine in 2014 through expanded vaccination efforts supported by PATH and our partners in Cambodia, India, and Laos. By 2017, the vaccine is expected to reach nearly 290 million people. Follow along to view how this lifesaving vaccine was introduced to communities around the world.